OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Dendritic cell-based vaccine: the state-of-the-art vaccine platform for COVID-19 management
Vivek P. Chavda, Aayushi Patel, Lalitkumar K. Vora, et al.
Expert Review of Vaccines (2022) Vol. 21, Iss. 10, pp. 1395-1403
Closed Access | Times Cited: 13
Vivek P. Chavda, Aayushi Patel, Lalitkumar K. Vora, et al.
Expert Review of Vaccines (2022) Vol. 21, Iss. 10, pp. 1395-1403
Closed Access | Times Cited: 13
Showing 13 citing articles:
Nanoparticle-Based Delivery Systems for Vaccines
Rajashri Bezbaruah, Vivek P. Chavda, Lawandashisha Nongrang, et al.
Vaccines (2022) Vol. 10, Iss. 11, pp. 1946-1946
Open Access | Times Cited: 124
Rajashri Bezbaruah, Vivek P. Chavda, Lawandashisha Nongrang, et al.
Vaccines (2022) Vol. 10, Iss. 11, pp. 1946-1946
Open Access | Times Cited: 124
Protein subunit vaccines: Promising frontiers against COVID-19
Vivek P. Chavda, Eswara Naga Hanuma Kumar Ghali, Pankti C. Balar, et al.
Journal of Controlled Release (2024) Vol. 366, pp. 761-782
Closed Access | Times Cited: 15
Vivek P. Chavda, Eswara Naga Hanuma Kumar Ghali, Pankti C. Balar, et al.
Journal of Controlled Release (2024) Vol. 366, pp. 761-782
Closed Access | Times Cited: 15
Fast-track development of vaccines for SARS-CoV-2: The shots that saved the world
Vivek P. Chavda, Qian Yao, Lalitkumar K. Vora, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 47
Vivek P. Chavda, Qian Yao, Lalitkumar K. Vora, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 47
Cell Membrane‐Coated Nanoparticles: A New Frontier in Immunomodulation
Nimeet Desai, Vishakha Tambe, Prasad Pofali, et al.
Advanced NanoBiomed Research (2024) Vol. 4, Iss. 8
Open Access | Times Cited: 8
Nimeet Desai, Vishakha Tambe, Prasad Pofali, et al.
Advanced NanoBiomed Research (2024) Vol. 4, Iss. 8
Open Access | Times Cited: 8
Conventional vaccination methods: Inactivated and live attenuated vaccines
Terrick Andey, Shailvi Soni, Shail Modi
Elsevier eBooks (2024), pp. 37-50
Closed Access | Times Cited: 5
Terrick Andey, Shailvi Soni, Shail Modi
Elsevier eBooks (2024), pp. 37-50
Closed Access | Times Cited: 5
Immunobiology and immunotherapy of COVID-19
Kenneth Lundström
Progress in molecular biology and translational science (2025)
Closed Access
Kenneth Lundström
Progress in molecular biology and translational science (2025)
Closed Access
Harnessing T-Cells for Enhanced Vaccine Development against Viral Infections
Zhen Zhuang, Jianfen Zhuo, Yaochang Yuan, et al.
Vaccines (2024) Vol. 12, Iss. 5, pp. 478-478
Open Access | Times Cited: 3
Zhen Zhuang, Jianfen Zhuo, Yaochang Yuan, et al.
Vaccines (2024) Vol. 12, Iss. 5, pp. 478-478
Open Access | Times Cited: 3
Vaccine safety, efficacy, and ethical considerations
Rashi K. Shukla, Krupa Vyas, Avinash Khadela, et al.
Elsevier eBooks (2024), pp. 311-324
Closed Access | Times Cited: 2
Rashi K. Shukla, Krupa Vyas, Avinash Khadela, et al.
Elsevier eBooks (2024), pp. 311-324
Closed Access | Times Cited: 2
Proteogenomics and immunopeptidomics in the development of advanced vaccines
Bedanta Bhattacharjee, Rajashri Bezbaruah, Damanbhalang Rynjah, et al.
Elsevier eBooks (2024), pp. 455-475
Closed Access | Times Cited: 1
Bedanta Bhattacharjee, Rajashri Bezbaruah, Damanbhalang Rynjah, et al.
Elsevier eBooks (2024), pp. 455-475
Closed Access | Times Cited: 1
Nanoparticle-based vaccines and future vaccine technologies
Srivatsa Surya Vasudevan, Tiba Yamin Kandrikar, Adil Ali Sayyed, et al.
Elsevier eBooks (2024), pp. 477-495
Closed Access | Times Cited: 1
Srivatsa Surya Vasudevan, Tiba Yamin Kandrikar, Adil Ali Sayyed, et al.
Elsevier eBooks (2024), pp. 477-495
Closed Access | Times Cited: 1
Nanotechnology and Vaccine Development
Keshava Jetha, Praful D. Bharadia, Manish P. Patel
(2024), pp. 63-93
Closed Access
Keshava Jetha, Praful D. Bharadia, Manish P. Patel
(2024), pp. 63-93
Closed Access
Vector-based vaccine delivery and associated immunity
Mohsen Akbarian, Lobat Tayebi, Elrashdy M. Redwan, et al.
Elsevier eBooks (2024), pp. 73-98
Closed Access
Mohsen Akbarian, Lobat Tayebi, Elrashdy M. Redwan, et al.
Elsevier eBooks (2024), pp. 73-98
Closed Access
Parenteral vaccine delivery
Keshava Jetha, Niva Rani Gogoi, Anup Kumar, et al.
Elsevier eBooks (2024), pp. 167-205
Closed Access
Keshava Jetha, Niva Rani Gogoi, Anup Kumar, et al.
Elsevier eBooks (2024), pp. 167-205
Closed Access
